Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy

Rama Jayaraj1 College of Health and Human Sciences, Charles Darwin University, Casuarina, Northern Territory 0909, AustraliaCorrespondence[email protected]

Chellan Kumarasamy2 University of Adelaide, Adelaide, South Australia 5005, Australia

Shanthi Sabarimurugan3 School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India

Suja Samiappan4 Department of Biochemistry, Bharathiar University, Coimbatore, Tamil Nadu, India

References

Zhang T, Feng F, Zhao W, et al. Comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy: a network meta-analysis. Cancer Manag Res. 2018;10:5869–5880. doi:10.2147/CMAR.S17617230510455
PubMed Web of Science ®Google Scholar
Ayyagari R, Tang D, Patterson-Lomba O, et al. Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: a network meta-analysis. Curr Med Res Opin. 2018;34(9):1645–1652. doi:10.1080/03007995.2018.147924629781326
PubMed Web of Science ®Google Scholar
Valentine JC, Pigott TD, Rothstein HR. How many studies do you need?: a primer on statistical power for meta-analysis. J Educ Behav Stat. 2010;35(2):215–247. doi:10.3102/1076998609346961
Web of Science ®Google Scholar

Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date